Real-world treatment patterns and health care resource use for patients with myelofibrosis: results from the METER study.

Blood Adv · 2025 · PMC11914159 · PMID 39729499

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

a positive trendno p-value reported

In the METER study, although the estimated median OS of 79.1 months showed a positive trend when compared with historic cohorts, 32 there still was a high number of hospitalizations and transfusion events in this real-world patient population, suggesting that unmet medical needs in MF persist.

also in 11,005 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.